bf/NASDAQ:CABA_icon.png

NASDAQ:CABA

Cabaletta Bio, Inc.

  • Stock

1.25

−5.30%

−0.35

USD last updated 22/08 01:02:51

Last Close

1.60

21/08 22:28

Market Cap

114.33M

Beta: 2.53

Volume Today

529.91K

Avg: 390.10K

PE Ratio

−15.75

PFCF: −19.39

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2-1.5-1-0.52018-03-302020-03-302021-11-012023-11-092024-11-07

    Revenue (Estimate*)

    246810122018-03-302020-03-302021-11-012023-11-092024-11-07

    *Estimate based on analyst consensus